CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-19 | Mendelson Daniel Newman Director | Purchase | +5,000 | $4.75 | $24K | 178,581 |
| 2023-11-03 | Brainin Robert Lawrence Director | Grant or award · Option to purchase Common Stock | +19,070 | $5.51 | $105K | 51,133 |
| 2023-11-03 | TOBIN SCOTT R Director | Grant or award · Option to purchase Common Stock | +28,600 | $5.51 | $158K | 28,600 |
| 2023-11-03 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +35,750 | $5.51 | $197K | 35,750 |
| 2023-11-03 | Mendelson Daniel Newman Director | Grant or award · Option to purchase Common Stock | +26,220 | $5.51 | $144K | 26,220 |
| 2023-11-03 | SIDRANSKY DAVID Director | Grant or award · Option to purchase Common Stock | +15,495 | $5.51 | $85K | 15,495 |
| 2023-11-03 | Breitfeld Philip P. Director | Grant or award · Option to purchase Common Stock | +15,495 | $5.51 | $85K | 15,495 |
| 2023-10-17 | ACKERMAN JOEL Director | Option exercise | +114,552 | $2.10 | $241K | 856,997 |
| 2023-10-17 | ACKERMAN JOEL Director | Option exercise · Option to purchase Common Stock | −100,000 | $2.10 | $210K | 0 |
| 2023-10-17 | ACKERMAN JOEL Director | Option exercise · Option to purchase Common Stock | −14,552 | $2.10 | $31K | 0 |
| 2023-10-11 | Mendelson Daniel Newman Director | Purchase | +5,000 | $6.40 | $32K | 163,081 |
| 2023-10-10 | Mendelson Daniel Newman Director | Purchase | +1,100 | $6.41 | $7K | 158,081 |
| 2023-10-09 | Davis Brady President | Grant or award · Option to purchase Common Stock | +135,000 | $6.50 | $878K | 135,000 |
| 2023-10-09 | Davis Brady President | Grant or award · Option to purchase Common Stock | +7,500 | $6.50 | $49K | 142,500 |
| 2023-10-09 | Davis Brady President | Grant or award · Option to purchase Common Stock | +68,000 | $6.50 | $442K | 210,500 |
| 2023-10-06 | Mendelson Daniel Newman Director | Purchase | +1,530 | $6.48 | $10K | 156,981 |
| 2023-10-05 | Mendelson Daniel Newman Director | Purchase | +2,000 | $6.47 | $13K | 155,451 |
| 2023-10-04 | Mendelson Daniel Newman Director | Purchase | +5,000 | $6.40 | $32K | 153,451 |
| 2023-10-03 | Mendelson Daniel Newman Director | Purchase | +2,500 | $6.30 | $16K | 148,451 |
| 2023-09-29 | Mendelson Daniel Newman Director | Purchase | +4,000 | $6.16 | $25K | 173,581 |
Page 3 of 20 · 398 trades